-
Product Insights
NewNet Present Value Model: Artelo Biosciences Inc’s ART-27.13
Overview Determining the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the current market, and knowledge of expected cash inflows, outflows, and potential success rates for each stage of drug development. GlobalData has done all of this work for you, Drugs Intelligence database to create high-value, risk-adjusted NPV models.
-
Product Insights
NewNet Present Value Model: Artelo Biosciences Inc’s ART-27.13
Determining the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the current market, and knowledge of expected cash inflows, outflows, and potential success rates for each stage of drug development. GlobalData has done all of this work for you, Drugs Intelligence database to create high-value, risk-adjusted NPV models.
-
Company Insights
NewInnovation and Patenting activity of Digital Arts Inc Q3 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Digital Arts Inc Q3 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Company Insights
NewInnovation and Patenting activity of Electronic Arts Inc Q3 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Electronic Arts Inc Q3 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Company Insights
NewInnovation and Patenting activity of Sun Art Retail Group Ltd Q3 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Sun Art Retail Group Ltd Q3 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report...
-
Sector Analysis
NewEU5 Assisted Reproductive Technology (ART) Procedures Count by Segments and Forecast to 2030
EU5 Assisted Reproductive Technology (ART) Procedures Market Report Overview The total number of Assisted Reproductive Technology (ART) procedures performed in EU5 was 671,095 in 2022. Assisted Reproductive Technology (ART) refers to reproductive health procedures that treat sub-fertile or infertile women or men such that pregnancy is more likely achieved. EU5 ART Procedures Market Outlook 2022-2030 (Number of Procedures) Buy the Full Report for More Insights on the EU5 ART Procedures Market Forecast Download a Free Sample Report The EU5 ART...
-
Sector Analysis
NewBRIC Assisted Reproductive Technology (ART) Procedures Count by Segments and Forecast to 2030
BRIC Assisted Reproductive Technology (ART) Procedures Market Report Overview The total number of Assisted Reproductive Technology (ART) procedures performed in BRIC was 1,804,730 in 2022. Assisted Reproductive Technology (ART) refers to reproductive health procedures that treat sub-fertile or infertile women or men such that pregnancy is more likely achieved. BRIC ART Procedures Market Outlook 2022-2030 (Number of Procedures) Buy the Full Report for More Insights on the BRIC ART Procedures Market Forecast Download a Free Sample Report The BRIC ART...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ART-6043 in Prostate Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. ART-6043 in Prostate Cancer Drug Details: ART-6043 is under development for the treatment of solid...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ART-6043 in Solid Tumor
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. ART-6043 in Solid Tumor Drug Details: ART-6043 is under development for the treatment of solid...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ARTS-021 in Lung Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. ARTS-021 in Lung Cancer Drug Details: ARTS-021 is under development for the treatment of metastatic...